Andrew C. Zeringue

MedTech CEO, Passionate about IO, happily married (19 yrs) father of 2 awesome kids & dad to 100,000 🐝 All through God’s grace.

[Andrew C. Zeringue @AndrewCZeringue]

Like and Follow the new #Theromics X page.

@Theromics_Inc

https://t.co/ek4XaVDe66

#VIR #InterventionalOncology #InterventionalRadiology #Abaltion

[Andrew C. Zeringue @AndrewCZeringue]

For 30+ years, everyone in tumor ablation has tried to improve the same thing: the probe, the generator, the energy.

We went the other way. Instead of changing the instrument, we're changing how the tissue responds to it.

We are pioneering Ablation Therapeutics™

[Theromics Inc @Theromics_Inc]

For two decades, image-guided ablation has gotten better at one thing: delivering energy.

Sharper probes. Smarter generators. More precise imaging.

But the tissue that energy is delivered into has stayed the same — unpredictable, uneven, and often the reason a tumor comes back. Local recurrence after local therapy still exceeds 30% in many settings.

We think the next advance in ablation isn't a better energy source. It's the tissue itself.

That's the idea behind Ablation Therapeutics™ — a new category focused on modifying the tumor environment so that existing ablation technologies can perform more predictably. It's the field Theromics was built to define.

Our investigational lead program, HeatSYNC™, is an injectable nanopolymer gel designed to work within the procedures physicians already perform — no new generators, no new probes — with the goal of improving treatment margins and reducing recurrence.

Same procedure. A more predictable result.

That's the future we're building toward.

#AblationTherapeutics #InterventionalOncology #MedTech #CancerInnovation #ImageGuidedTherapy

—
HeatSYNC™ is investigational and has not been cleared or approved by the FDA.

[Theromics Inc @Theromics_Inc]

Over the past several weeks, the Theromics team has had the privilege of engaging with clinicians, innovators, investors, strategic partners, and patient advocates across the medtech ecosystem.

From MedTech MVP and the Wilson Sonsini Medical Device & Digital Health Conference to the Mayo Clinic Cardiology & Radiology Innovation Summit and the Mary Bird Perkins Cancer Center Survivor Day Butterfly Release, every conversation reinforced the importance of collaboration in advancing the future of cancer care.

We're grateful to the organizers and everyone who took the time to share ideas, challenge assumptions, and discuss new approaches to improving patient outcomes.

The future of local cancer therapy will be built together.

#Theromics #MedTech #MedicalDevices #InterventionalRadiology #CancerCare #Innovation #MedTechInnovation #AblationTherapy

[Andrew C. Zeringue @AndrewCZeringue]

It's an honor to lead @Theromics_Inc into our next phase with this amazing nanopolomer gel technolgy.

#HeatSYNC #AblationTherapeutics #Theromics #Ablation

[Theromics Inc @Theromics_Inc]

Theromics Inc. is pleased to welcome Andrew C. Zeringue as Chief Executive Officer.

Andrew brings nearly two decades of interventional oncology and thermal ablation leadership experience and a proven track record bringing emerging technologies from FDA clearance through early commercialization and scalable market adoption.

His appointment comes as Theromics prepares for an important stage of growth as we continue to advance our HeatSYNC™ gel platform, designed to enhance thermal energy transfer within soft tissue during ablation procedures, toward FDA approval.

Under Andrew’s leadership Theromics is poised to fulfill its mission to provide more predictable and effective energy delivery and improved treatment while addressing the challenge of local tumor recurrence following ablation procedures.

Read the press release for more: https://t.co/UxkPOby14t

#MedTech #InterventionalOncology #TumorAblation #AblationTherapeutics #CancerCare #Theromics @DamianDupuy @AndrewCZeringue

[Andrew C. Zeringue @AndrewCZeringue]

I'm looking forward to colaborating with other innovators & investors in the MedTech space to move Ablation Therapeutics one step closer to clincal use.
#HeatSYNC #Theromics #AblationTherapeutics

[Theromics Inc @Theromics_Inc]

Theromics is looking forward to attending the @wilsonsonsini Medical Device & Digital Health Conference (#MDC2026) this week in San Francisco.

Representing Theromics will be our CEO, @AndrewCZeringue , who will be meeting with investors, strategic partners, clinicians, and industry leaders who share our vision for the future of ablation therapeutics.

At Theromics, we believe the next frontier in local tumor therapy is not simply new devices, but technologies designed to improve how energy is delivered, controlled, and understood within tissue. Our mission is to develop solutions that support more predictable treatment-zone control and ultimately help address the challenge of local recurrence following local therapy.

If you'll be attending MDC 2026, we welcome the opportunity to connect and discuss the future of interventional oncology, tumor ablation, and ablation therapeutics.

#MDC2026 #Theromics #InterventionalOncology #TumorAblation #AblationTherapeutics #MedicalDevices #MedTech #HealthcareInnovation

[Theromics Inc @Theromics_Inc]

Interventional Oncology has transformed cancer care, but local cancer recurrence remains a major challenge.

At Theromics, we believe the next frontier is better control of ablation therapy through 𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬.

#InterventionalOncology #Ablation

[Andrew C. Zeringue @AndrewCZeringue]

@drcostantino1 @JillSommerset Looking phenominal in your Moonrise Medical swag!!!!

[Andrew C. Zeringue @AndrewCZeringue]

@MayoRadiology @MerveOzenMD @JVIRmedia Congratulations Dr Ozen!!!

[Andrew C. Zeringue @AndrewCZeringue]

1,000 lives changed!!!
This achievement is the result of the dedication of everyone at @QuantumSurgical, past and present, and the support of all our ablation manufacturer partners. Without them, we’d simply be a robot without a destination.

Bravo!!!

[Andrew C. Zeringue @AndrewCZeringue]

@MerveOzenMD That's amazing!

[Andrew C. Zeringue @AndrewCZeringue]

@OmsaRadsig36738 Should be a great event as always!

[James Milburn MD, FACR, FSNIS, MMM @docroc99]

Ochsner Health in New Orleans will hold a Virtual Open House for both Diagnostic Radiology and Interventional Radiology programs Thursday, Sept. 11 at 7pm CDT. Register and submit questions using the QR codes. @TheRadRoom #FutureRadRes #MedStudents #Match2026 @OchsnerRads

[Andrew C. Zeringue @AndrewCZeringue]

Robotics in Image Guided Ablations - join the upcoming webinar on Tuesday September 9, featuring a live Q&A!

Get your questions answered by the experts.

➡️ Register today: https://t.co/fKfWHzWyaf

#medtech #interventionalradiology #roboticsurgery

[Andrew C. Zeringue @AndrewCZeringue]

@MayoClinicAZ_IR @SemInterventRad Congratulations!!!

[Andrew C. Zeringue @AndrewCZeringue]

Dr. Brad Wood discusses how robotics supports interventional radiology teams in the Discovering Hope in Science podcast!

[Brad Wood @BradWoodMD]

Robots in Interventional Radiology!
https://t.co/iw5bCaqOEY

[Quantum Surgical @QuantumSurgical]

Dr. Brad Wood discusses how robotics supports interventional radiology teams in the Discovering Hope in Science podcast!

[Andrew C. Zeringue @AndrewCZeringue]

@BradWoodMD Appreciate you sharing this episode! Exciting to see our two years of efforts finally come to life.
I'm not sure we get here without Lindsey keeping our heads screwed on...

[Andrew C. Zeringue @AndrewCZeringue]

@MayoClinicAZ_IR @MerveOzenMD @rahmioklu @DanPatelMD @alwallace That's a lot a brain power at one table with some amazing people!

[Andrew C. Zeringue @AndrewCZeringue]

@RichDuszak A large majority of Jaws 1 & 2 was shot in Pensacola, FL. My uncle who is from there has some cool stories of hanging with cast nightly at bars. Every day they flew reels of film back to Hollywood CA.

[Andrew C. Zeringue @AndrewCZeringue]

@IR_Doctor I think I'm seeing a fluffy head and a smaller frame... Alpacas